Rare milestone for Canadian biotech as Zymeworks-developed drug gets FDA approval
- Posted on November 21, 2024
- By The Globe and Mail
- 2 Views
Rare milestone for Canadian biotech as Zymeworks-developed drug gets FDA approval
Jazz Pharmaceuticals says the U.S. Food and Drug Administration has approved use of the tumor-fighting antibody to treat adults with a form of biliary-tract cancer (BTC)
